Prosecution Insights
Last updated: April 19, 2026

Dermavant Sciences GmbH

3 pending office actions

Portfolio Summary

3
Total Pending OAs
1
Final Rejections
2
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18546880 REMITTIVE EFFECTS OF TAPINAROF IN THE TREATMENT OF PLAQUE PSORIASIS, ATOPIC DERMATITIS, OR RADIATION DERMATITIS SEITZ, ANTHONY JOSEPH 1629 Non-Final OA Aug 17, 2023
18002511 TOPICAL PHARMACEUTICAL COMPOSITIONS YOUNG, MICAH PAUL 1618 Final Rejection Dec 20, 2022
17820692 REMITTIVE EFFECTS OF TAPINAROF IN THE TREATMENT OF PLAQUE PSORIASIS, ATOPIC DERMATITIS, OR RADIATION DERMATITIS COPPINS, JANET L 1628 Non-Final OA Aug 18, 2022

Managing Dermavant Sciences GmbH's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month